Leading the way to safer medication
 Crosscheck  Recommender

Alipogene tiparvovec

Description

Alipogene tiparvovec contains the human lipoprotein lipase (LPL) gene variant LPLS447X in a vector. The human LPL gene variant LPLS447X in an adeno-associated virus serotype 1 (AAV1) vector intended to target the muscle. Alipogene tiparvovec is injected as a one-time series into the muscle of the lower extremities where it is taken up by myocytes.

Medicine classification

ATC Code
Title
Class
C10AX10
Alipogene tiparvovec
C Cardiovascular system → C10 Lipid modifying agents → C10A Lipid modifying agents, plain → C10AX Other lipid modifying agents

Medicines

Drug
Countries

Lithuania

Product monographs

Monograph
Type
Country
GLYBERA Solution for injection
MPI, EU: SmPC